Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Michael B Yaffe

Showing results (81-90 of 267) with videos related to

Pageof 27
Sort By:
Nature Communications|September 8, 2022
Multi-pathway DNA-repair reporters reveal competition between end-joining, single-strand annealing and homologous recombination at Cas9-induced DNA double-strand breaksBert van de Kooij, Alex Kruswick, Haico van Attikum, et al.
Cancer Cell|February 13, 2007
p53-deficient cells rely on ATM- and ATR-mediated checkpoint signaling through the p38MAPK/MK2 pathway for survival after DNA damageH Christian Reinhardt, Aaron S Aslanian, Jacqueline A Lees, et al.
Bioorganic & Medicinal Chemistry Letters|September 4, 2018
Histidine N(τ)-cyclized macrocycles as a new genre of polo-like kinase 1 polo-box domain-binding inhibitorsDavid Hymel, Robert A Grant, Kohei Tsuji, et al.
The Biochemical Journal|January 5, 2005
The transcriptional co-activator TAZ interacts differentially with transcriptional enhancer factor-1 (TEF-1) family membersWilliam M Mahoney, Jeong-Ho Hong, Michael B Yaffe, et al.
Cell Cycle (Georgetown, Tex.)|January 9, 2004
The Polo-box domain: a molecular integrator of mitotic kinase cascades and Polo-like kinase functionDrew M Lowery, Duaa H Mohammad, Andrew E H Elia, et al.
Nature|September 24, 2005
Natural-like function in artificial WW domainsWilliam P Russ, Drew M Lowery, Prashant Mishra, et al.
Cancer Research|October 3, 2008
Validation of the p21-activated kinases as targets for inhibition in neurofibromatosis type 2Chunling Yi, Erik W Wilker, Michael B Yaffe, et al.
Molecular & Cellular Oncology|April 11, 2022
Immunogenic cell stress and injury versus immunogenic cell death: implications for improving cancer treatment with immune checkpoint blockadeGanapathy Sriram, Tiffany R Emmons, Lauren E Milling, et al.
Current Trauma Reports|September 1, 2020
Modern Management of Bleeding, Clotting, and Coagulopathy in Trauma Patients: What Is the Role of Viscoelastic Assays?Sanjeev Dhara, Ernest E Moore, Michael B Yaffe, et al.
Molecular Cell|January 22, 2003
A novel assay system implicates PtdIns(3,4)P(2), PtdIns(3)P, and PKC delta in intracellular production of reactive oxygen species by the NADPH oxidaseGlenn E Brown, Mary Q Stewart, Hui Liu, et al.
Pageof 27

Showing results (81-90 of 267) with videos related to

Sort By:
Pageof 27
Nature Communications|September 8, 2022
Multi-pathway DNA-repair reporters reveal competition between end-joining, single-strand annealing and homologous recombination at Cas9-induced DNA double-strand breaksBert van de Kooij, Alex Kruswick, Haico van Attikum, et al.
Cancer Cell|February 13, 2007
p53-deficient cells rely on ATM- and ATR-mediated checkpoint signaling through the p38MAPK/MK2 pathway for survival after DNA damageH Christian Reinhardt, Aaron S Aslanian, Jacqueline A Lees, et al.
Bioorganic & Medicinal Chemistry Letters|September 4, 2018
Histidine N(τ)-cyclized macrocycles as a new genre of polo-like kinase 1 polo-box domain-binding inhibitorsDavid Hymel, Robert A Grant, Kohei Tsuji, et al.
The Biochemical Journal|January 5, 2005
The transcriptional co-activator TAZ interacts differentially with transcriptional enhancer factor-1 (TEF-1) family membersWilliam M Mahoney, Jeong-Ho Hong, Michael B Yaffe, et al.
Cell Cycle (Georgetown, Tex.)|January 9, 2004
The Polo-box domain: a molecular integrator of mitotic kinase cascades and Polo-like kinase functionDrew M Lowery, Duaa H Mohammad, Andrew E H Elia, et al.
Nature|September 24, 2005
Natural-like function in artificial WW domainsWilliam P Russ, Drew M Lowery, Prashant Mishra, et al.
Cancer Research|October 3, 2008
Validation of the p21-activated kinases as targets for inhibition in neurofibromatosis type 2Chunling Yi, Erik W Wilker, Michael B Yaffe, et al.
Molecular & Cellular Oncology|April 11, 2022
Immunogenic cell stress and injury versus immunogenic cell death: implications for improving cancer treatment with immune checkpoint blockadeGanapathy Sriram, Tiffany R Emmons, Lauren E Milling, et al.
Current Trauma Reports|September 1, 2020
Modern Management of Bleeding, Clotting, and Coagulopathy in Trauma Patients: What Is the Role of Viscoelastic Assays?Sanjeev Dhara, Ernest E Moore, Michael B Yaffe, et al.
Molecular Cell|January 22, 2003
A novel assay system implicates PtdIns(3,4)P(2), PtdIns(3)P, and PKC delta in intracellular production of reactive oxygen species by the NADPH oxidaseGlenn E Brown, Mary Q Stewart, Hui Liu, et al.
Pageof 27